Mayo Clinic Endocrine Update 2021 is a conference dedicated to best practices, barriers to optimal patient outcomes and new approaches to evaluation and management of complex and common endocrine and metabolic disorders.
Mayo Clinic Endocrine Update 2021 covers topics such as:
- Potential complications with the use of SGLT 2 inhibitors
- Improving cardiovascular outcomes of an idetified patient who would benefit from SGLT 2 inhibitors in the management of Type 2 diabetes
- Endocrine-related adverse effects of immune checkpoint inhibitors for both clinical and diagnostic approaches
- The indications for immune checkpoint inhibitors in cancer therapies
- The genomics of medullary thyroid cancer
- Treatment strategies for checkpoint-induced endocrinopathies
- Treatment strategies for patients with MTC, when to start systemic therapy, which drug to use first, and salvage therapy options for treatment of refractory disease
- Current and recently approved systemic treatment options for patients with advanced medullary thyroid cancer
- Factors that contribute to bone loss after bariatric surgery to prevent metabolic bone disease
Mayo Clinic Endocrine Update 2021 brings together practicing endocrinologists, endocrine surgeons and internists who care for patients with endocrine disorders.
